Peter Moesta spoke on November 15th at the 2016 edition of the Biomanufacturing World Summit. His keynote presentation was entitled, The Role of Manufacturing in a Successful Biosimilar Strategy.
Peter Moesta has more than 30 years of experience in the biopharmaceutical industry and a strong understanding of manufacturing and launching complex biologics. Before joining TPI, he was senior vice president of Biologics Manufacturing at Bristol-Myers Squibb, where he oversaw the development, production and worldwide launch of numerous significant biologics, including oncology products Yervoy and Opdivo. Previous to this role, Peter held various leadership positions in biologics development and manufacturing at Abbott Laboratories and BASF AG.